Subscriptions are live: We're on the subscription model now, early-access price $24.99/month, with day, week, and longer plans too. New accounts start with 5 free premium days. Prefer to donate? Donations grant premium time and are logged on your profile page.

$NVS

Novartis AG

XNYS

$154.28-0.10%$0.1600Prev $154.44LIVE Full chart Live alerts
No recent price bars, the chart lights up when NVS starts printing.

Why is NVS down today? It is at $154.28 (-0.10%), and our scanner flagged it 18 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment NVS spikes, and full due diligence on NVS — key stats, earnings, dilution and insider activity. Free.

Free alerts

Get free $NVS alerts the moment volume spikes

Our scanner flagged $NVS 18 times in the last 30 days. Create a free account to track $NVS, build a watchlist, and get instant unusual-volume alerts — plus 5 free premium days, no card needed.

Real-time RVOL & momentum alerts Personal watchlist & price alerts
Sign up free with email

No card · 5 premium days · join 800+ traders

Key Stats

Price & performance
Price
$154.28
Change today
-0.10%
Previous close
$154.44
52-week range
$114.38 – $170.46
Valuation & dividend
Market cap
$294.69B
Dividend yield
3.07% ($4.74)
Ownership & volume
Institutional own.
7.20%
Total held
7.2%
Tradeable float
1.77B
93% of shares · after 7% institutions
Short interest
5.7M
▲ +7% vs prior · as of 2026-07-15
Short % of float
0.3%
Days to cover
3.6d
Avg daily volume
1.8M
Classification
Exchange
XNYS
Relative volumevs this time of day
5m
0.8x
15m
0.9x
1h
0.5x
1D
0.1x

Get free NVS + market alerts in your inbox

The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.

No spam. Unsubscribe anytime. Not investment advice.

Why is $NVS moving today?

Fresh news

Here is the latest on NVS from our scanner (live price and day move above). A recent catalyst in the news: “BioAge Labs Reports Second Quarter 2026 Financial Results and Provides Business Updates.”

Likely catalystForeign issuer report (6-K), from the latest SEC filing. Read it →
Why is $NVS moving? →▶ Replay the moveAuto-generated from live scanner data. Not investment advice.
Trading profileShortableEasy to borrowNo SSRBorrow via Alpaca · SSR from Reg SHO 201
$NVS is down 0.1% today and has a recent share offering on file. See who may be selling into moves →

Dilution watch

Recent offering

Recent priced share offering — a one-time sale that has already completed (not ongoing). If $NVS runs, these filings show who may be positioned to sell new or newly-registered shares into the move.

Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.

$NVS Sentiment

Bullish
Bearish78Bullish
📰 News: 5 bull · 0 bearToday: -0.1%👥 Community: 0 bull · 0 bear

Blend of news sentiment, today’s move, and community votes. Not investment advice.

$NVS Activity

News, unusual-volume alerts, AI-trader trades and community chatter — the whole story, newest first.

News· GlobeNewswire Inc.· 17h ago Neutral
BioAge Labs Reports Second Quarter 2026 Financial Results and Provides Business Updates
Alert· 1d ago 10.2× RVOL
NVS hit 10.229x RVOL at 8:03 AM ET
at $155.05
Alert· 2d ago -0.4% vs EMA
$NVS near 200 EMA: -0.43% from 200 EMA at 12:55 PM ET
at $153.56
Alert· 2d ago 13.8× RVOL
NVS hit 13.840x RVOL at 12:55 PM ET
at $153.56
Alert· 2d ago -1.2% vs EMA
$NVS near 200 EMA: -1.20% from 200 EMA at 11:31 AM ET
at $153.21
Alert· 2d ago 5.7× RVOL
NVS hit 5.686x RVOL at 11:31 AM ET
at $153.21
Alert· 3d ago 5.4× RVOL
NVS hit 5.402x RVOL at 9:25 AM ET
at $155.24
Alert· 6d ago -0.5% vs EMA
$NVS near 200 EMA: -0.48% from 200 EMA at 8:30 AM ET
at $156.96
Alert· 6d ago 5.2× RVOL
NVS hit 5.217x RVOL at 8:30 AM ET
at $156.96
Alert· 6d ago 23.7× RVOL
NVS hit 23.744x RVOL at 7:20 AM ET
at $156.75
Alert· 7d ago 7.3× RVOL
NVS hit 7.344x RVOL at 9:29 AM ET
at $156.89
Alert· 7d ago 8.0× RVOL
NVS hit 8.005x RVOL at 2:01 PM ET
at $158.75
Alert· 13d ago 2.8× RVOL
NVS hit 2.824x RVOL at 9:30 AM ET
at $156.08
News· The Motley Fool· 15d ago Neutral
Cathie Wood's $362 Million CRISPR Therapeutics Bet Isn't Just Bold -- It's Backed by a Catalyst Many Investors Are Underrating
News· GlobeNewswire Inc.· 15d ago Bullish
Global Cancer Biomarkers Market to Reach $37.8 Billion by 2035 as Precision Oncology Adoption Accelerates - Trends and Forecasts Till 2035
Alert· 15d ago 31.6× RVOL
NVS hit 31.640x RVOL at 10:56 AM ET
at $154.30
Alert· 16d ago +1.19%
$NVS moved +1.19% in 1 min (Level 1) at 9:29 AM ET
at $155.56
Alert· 16d ago 20.5× RVOL
NVS hit 20.515x RVOL at 9:28 AM ET
at $154.50
Alert· 16d ago +0.7% vs EMA
$NVS near 200 EMA: +0.65% from 200 EMA at 9:26 AM ET
at $154.05
Alert· 16d ago 4.3× RVOL
NVS hit 4.272x RVOL at 9:26 AM ET
at $154.05
Alert· 16d ago +0.8% vs EMA
$NVS near 200 EMA: +0.84% from 200 EMA at 8:23 AM ET
at $154.11
Alert· 16d ago 6.0× RVOL
NVS hit 5.964x RVOL at 8:23 AM ET
at $154.11
Alert· 16d ago +0.9% vs EMA
NVS 200EMA (1m) Trending · 50 bars · L3 · +0.87% above EMA · slope +0.34%
at $154.06
Alert· 16d ago +1.1% vs EMA
$NVS near 200 EMA: +1.15% from 200 EMA at 7:50 AM ET
at $154.33
Alert· 16d ago -1.02%
$NVS moved -1.02% in 1 min (Level 1) at 7:50 AM ET
at $154.33
Alert· 16d ago +2.5% vs EMA
$NVS near 200 EMA: +2.46% from 200 EMA at 7:15 AM ET
at $155.84
Alert· 16d ago 20.3× RVOL
NVS hit 20.308x RVOL at 7:15 AM ET
at $155.84
Alert· 16d ago +3.0% vs EMA
$NVS near 200 EMA: +2.99% from 200 EMA at 6:56 AM ET
at $156.17
News· SEC EDGAR· 16d ago
NOVARTIS AG filed a Foreign issuer report (6-K)
News· GlobeNewswire Inc.· 16d ago Bullish
Antiparasitic Drugs Market Report Released — Examines Antimalarials, Anthelmintics, Antiprotozoals, Ectoparasiticides, and Neglected Tropical Disease Therapies
News· GlobeNewswire Inc.· 20d ago Bullish
Novartis Fabhalta® (iptacopan) receives FDA traditional approval as first and only complement inhibitor to significantly slow kidney function decline in primary IgAN
News· GlobeNewswire Inc.· 21d ago Bullish
Autoimmune Disease Therapeutics Market Size to Reach USD 137.85 Billion by 2035 as Biologics and Precision Medicine Drive Growth | SNS Insider
News· The Motley Fool· 27d ago Bullish
Novartis vs. Teva: Which Pharmaceutical Stock Is a Better Buy in 2026?

Also moving today

The tickers our scanner is lighting up most over the last 48 hours.

NVS stock FAQ

Why is $NVS moving today?

Here is the latest on NVS from our scanner (live price and day move above). A recent catalyst in the news: “BioAge Labs Reports Second Quarter 2026 Financial Results and Provides Business Updates.”

What is the NVS stock price today?

NVS last traded at $154.28, down 0.10% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).

Does NVS pay a dividend?

Yes. NVS currently has a dividend yield of about 3.07% ($4.74 per share per year). Dividend figures can change; this is not investment advice.

Where can I see live NVS alerts?

The NVS Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged NVS 18 times in the last 30 days.

What exchange is NVS on?

NVS (Novartis AG) trades on XNYS, with a market cap of about $294.69B.

Is NVS good for day trading?

That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge NVS for yourself. This is not investment advice.

Live data from TheDesperateTrader scanner. Not investment advice.